Astrana Health Inc [ASTH] stock is trading at $27.6, up 3.45%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ASTH shares have gain 7.48% over the last week, with a monthly amount glided 15.63%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Astrana Health Inc [NASDAQ: ASTH] stock has seen the most recent analyst activity on December 12, 2025, when Needham initiated its Buy rating and assigned the stock a price target of $28. Previously, Barclays started tracking the stock with Equal Weight rating on April 01, 2025, and set its price target to $36. On October 14, 2024, TD Cowen initiated with a Buy rating and assigned a price target of $66 on the stock. KeyBanc Capital Markets started tracking the stock assigning a Sector Weight rating. Truist upgraded its rating to a Buy and raised its price target to $50 on July 11, 2024. Robert W. Baird started tracking with an Outperform rating for this stock on May 30, 2024, and assigned it a price target of $54. In a note dated February 26, 2024, Jefferies initiated a Buy rating and provided a target price of $50 on this stock.
Astrana Health Inc [ASTH] stock has fluctuated between $20.12 and $39.97 over the past year. Currently, Wall Street analysts expect the stock to reach $30.33 within the next 12 months. Astrana Health Inc [NASDAQ: ASTH] shares were valued at $27.6 at the most recent close of the market. An investor can expect a potential return of 9.89% based on the average ASTH price forecast.
Analyzing the ASTH fundamentals
Astrana Health Inc [NASDAQ:ASTH] reported sales of 2.90B for the trailing twelve months, which represents a growth of 99.71%. Gross Profit Margin for this corporation currently stands at 0.1% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is 0.0%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.01 and Total Capital is 0.04. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.4.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Astrana Health Inc’s Current Ratio is 1.40. Also, the Quick Ratio is 1.40, while the Cash Ratio stands at 0.73. Considering the valuation of this stock, the price to sales ratio is 0.48, the price to book ratio is 1.76 and price to earnings (TTM) ratio is 145.26.
